What Does the Centre's 1st National Call for the Rs 2,000 crore BIRAC–RDI Fund Mean for the Biotech Sector?
Synopsis
The Indian government is taking a bold step forward by launching the Rs 2,000 crore BIRAC–RDI Fund to strengthen the biotech sector. This initiative is expected to transform India's position in the global bioeconomy and foster innovation in various industries.
Key Takeaways
The Indian government has launched the Rs 2,000 crore BIRAC–RDI Fund.
This fund is part of a larger Rs 1 lakh crore RDI initiative.
It aims to support high-risk biotech research and bridge the gap to industrial manufacturing.
India's biotech startup ecosystem has grown from 50 to over 11,000 in less than a decade.
The bioeconomy in India is rapidly expanding, with a value projected to grow significantly.
New Delhi, Feb 13 (NationPress) The government has given the green light for the inaugural national call for the Rs 2,000 crore BIRAC–RDI Fund, which falls under the larger Rs 1 lakh crore Research, Development, and Innovation (RDI) initiative aimed at enhancing the biotech sector.
Union Minister Dr. Jitendra emphasized that this launch marks a pivotal change in India's strategy towards science-driven growth, indicating that the nation is now a frontrunner in emerging technologies rather than a latecomer.
He noted that the transformation is evident in the burgeoning startup landscape — expanding from approximately 50 biotech startups in 2014 to over 11,000 today, which he described as a quantum leap in both scale and ambition.
The bioeconomy, valued at nearly $8 billion in 2014, has seen rapid growth, positioning India among the foremost global players.
The minister added that biotechnology is set to spearhead the next wave of industrial development, akin to how information technology catalyzed India's previous transformation.
“The upcoming industrial revolution will be fueled by biotech innovation, advanced manufacturing, and new-age entrepreneurship,” he remarked.
Dr. Rajesh S. Gokhale, Secretary of the Department of Biotechnology and Director General of BRIC, stated, “The RDI Fund has been designed to support long-term, high-risk research that requires patient capital and sophisticated infrastructure.”
He also mentioned that this initiative complements the BioE3 Policy and outlines a framework for developing next-gen products across sectors such as biopharma, bio-industrial manufacturing, bioenergy, blue economy, and biocomputation.
Its goal is to transition from research outputs to scalable industrial results.
The BIRAC–RDI Fund is part of the national RDI initiative ratified by the Union Cabinet in July 2025 and launched in November 2025 under the Anusandhan National Research Foundation (ANRF).
The fund is intended to close the gap between lab research and industrial-scale production by supporting technologies from TRL-4 to TRL-9 through a combination of equity, convertible instruments, and long-term debt.
Over the last decade, BIRAC has established a comprehensive innovation ecosystem, which includes more than 100 bio-incubation centres, over 10 lakh square feet of incubation space, and connections with more than 15 lakh startup entrepreneurs.
Point of View
This initiative aligns seamlessly with India's goal to enhance its scientific capabilities and promote innovation. The BIRAC-RDI Fund is a critical step in ensuring that India remains competitive in the global biotech market, fostering entrepreneurship and technological advancement.
NationPress
1 May 2026
Frequently Asked Questions
What is the purpose of the BIRAC–RDI Fund?
The BIRAC–RDI Fund aims to support long-term, high-risk research in biotechnology, facilitating the transition from laboratory findings to scalable industrial applications.
How does the BIRAC–RDI Fund support startups?
The fund provides a mix of equity, convertible instruments, and long-term debt to help bridge the gap between research and industrial manufacturing.
What impact will this fund have on the Indian biotech sector?
The fund is expected to significantly boost the biotech sector, promoting innovation and positioning India as a global leader in the bioeconomy.
